中東およびアフリカのバイオプロダクション市場予測 2030年 - 地域別分析 - 製品別（生物製剤およびバイオシミラー、ワクチン、細胞および遺伝子治療、核酸治療、その他）、用途別（関節リウマチ、血液疾患、がん、糖尿病、心血管疾患、その他）、機器別（上流機器、下流機器、バイオリアクター、消耗品および付属品）、エンドユーザー別（バイオ医薬品会社、契約製造組織、その他）
自動化された細胞療法製造への移行が中東およびアフリカのバイオ製造市場を後押し
自動化は、汚染リスクの低減、一貫性の向上、製造コストの削減など、細胞療法の開発者に多くのメリットをもたらします。多くの企業が自動化を可能にするデバイスを提供しており、たとえばLonza CocoonやMiltenyiのCliniMACS Prodigyシステムは、CAR-Tプロセスのほとんどの連続ユニット操作を単一システム内で自動化できるように設計されています。細胞療法の増加により、細胞療法製品の生産は世界中で少量から大量へと移行しています。さらに、細胞療法は学術・臨床の現場から大量生産・商業化へと進化しており、製造の自動化の需要が高まっています。細胞療法の研究活動の増加により、高度な製造ソリューションの需要が高まっています。これを受けて、多くの企業が学術研究者や大手バイオテクノロジー企業のデジタルニーズを満たす製品を提供しています。たとえば、2019年5月、GEヘルスケアは細胞療法のワークフロー全体をサポートするChronicleウェブアプリケーションをリリースしました。Chronicle自動化ソフトウェアは、複雑な細胞療法プロセスの開発と製造を最適化するように設計された、適正製造基準（GMP）に準拠したデジタルソリューションです。
企業は細胞療法の自動化のための戦略的および技術的な開発にも参入しています。たとえば、2020年7月、サーモフィッシャーサイエンティフィック社とライエルイムノファーマ社は提携し、がん患者に効果的な細胞療法を設計するためのプロセスの開発と製造を行いました。このパートナーシップの下、両社はT細胞の適応性を向上させ、試薬、消耗品、機器とともに、統合されたcGMP（現在の適正製造基準）準拠プラットフォーム（システムとソフトウェア）の開発をサポートすることを目指しています。したがって、細胞療法メーカーによる自動化の採用の増加が市場を牽引すると予想されます。
中東およびアフリカのバイオプロダクション市場の概要
中東およびアフリカのバイオプロダクション市場には、UAE、サウジアラビア、南アフリカ、その他の中東およびアフリカの国レベルの分析が含まれています。バイオプロダクション市場の成長は、政府の政策の変更、官民パートナーシップの増加、医療インフラの改善に起因しています。さらに、高度で効果的な細胞療法に対する需要の高まりが市場の成長を促進しています。
国際薬剤経済学およびアウトカム研究学会（ISPOR）によると、心血管疾患は2020年にサウジアラビアで最も多い死因であり、すべての死亡例の45.7％を占めました。さらに、サウジアラビアでは不健康な食習慣と座りがちな生活習慣により、糖尿病の有病率が高くなっています。IDFによると、サウジアラビアでの糖尿病の頻度率は2021年に8％から22％の範囲でした。糖尿病の主な要因は、肥満、不健康な生活習慣、遺伝的感受性です。全国調査によると、サウジアラビアの心血管疾患の有病率は2022年に5.5％でした。したがって、サウジアラビアでの心血管疾患と糖尿病の発生率の増加は、バイオプロダクション市場の成長を牽引しています。
中東およびアフリカのバイオプロダクション市場の収益と2030年までの予測（百万米ドル）
中東およびアフリカのバイオプロダクション市場のセグメンテーション
中東およびアフリカのバイオプロダクション市場は、製品、アプリケーション、機器、エンドユーザー、および国に分類されています。
製品別に見ると、中東およびアフリカのバイオプロダクション市場は、生物製剤およびバイオシミラー、ワクチン、細胞および遺伝子治療、核酸治療、その他に分類されています。生物製剤およびバイオシミラーセグメントは、2022年に中東およびアフリカのバイオプロダクション市場で最大のシェアを占めました。
用途別に見ると、中東およびアフリカのバイオプロダクション市場は、関節リウマチ、血液疾患、がん、糖尿病、心血管疾患、その他に分類されています。がんセグメントは、2022年に中東およびアフリカのバイオプロダクション市場で最大のシェアを占めました。
機器別に見ると、中東およびアフリカのバイオプロダクション市場は、上流機器、下流機器、バイオリアクター、消耗品および付属品に分かれています。消耗品および付属品セグメントは、2022年に中東およびアフリカのバイオプロダクション市場で最大のシェアを占めました。
エンドユーザー別に見ると、中東およびアフリカのバイオプロダクション市場は、バイオ医薬品会社、契約製造組織、その他に分類されています。バイオ医薬品企業セグメントは、2022年に中東およびアフリカのバイオプロダクション市場で最大のシェアを占めました。
国別に見ると、中東およびアフリカのバイオプロダクション市場は、サウジアラビア、UAE、南アフリカ、その他の中東およびアフリカに分かれています。サウジアラビアは、2022年に中東およびアフリカのバイオプロダクション市場シェアを独占しました。
Lonza Group AG、Danaher Corp、Sartorius AG、Thermo Fisher Scientific Inc、Merck KGaA、F. Hoffmann-La Roche Ltd、Bio-Rad Laboratories Inc.は、中東およびアフリカのバイオプロダクション市場で事業を展開している大手企業の一部です。
Table of Content
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Bioproduction Market - Key Industry Dynamics
4.1 Market Drivers
4.1.1 Rising Adoption of Regenerative Medicines
4.1.2 Increasing Prevalence of Chronic Diseases
4.2 Market Restraints
4.2.1 High Cost of Cell Therapy and Biosimilar Manufacturing
4.3 Market Opportunities
4.3.1 Patent Expiry of Blockbuster Biologics
4.4 Future Trends
4.4.1 Shift Toward Automated Cell Therapy Manufacturing
4.5 Impact Analysis
5. Bioproduction Market - Middle East & Africa Market Analysis
5.1 Middle East & Africa Bioproduction Market Revenue (US$ Mn), 2020 - 2030
6. Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 - by Product
6.1 Overview
6.2 Middle East & Africa Bioproduction Market Revenue Share, by Product 2022 & 2030 (%)
6.3 Biologics and Biosimilars
6.3.1 Overview
6.3.2 Biologics and Biosimilars: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Vaccines
6.4.1 Overview
6.4.2 Vaccines: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Cell and Gene Therapies
6.5.1 Overview
6.5.2 Cell and Gene Therapies: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.6 Nucleic Acid Therapeutics
6.6.1 Overview
6.6.2 Nucleic Acid Therapeutics: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
6.7 Others
6.7.1 Overview
6.7.2 Others: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7. Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 - by Application
7.1 Overview
7.2 Middle East & Africa Bioproduction Market Revenue Share, by Application 2022 & 2030 (%)
7.3 Cancer
7.3.1 Overview
7.3.2 Cancer: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Cardiovascular Diseases
7.4.1 Overview
7.4.2 Cardiovascular Diseases: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Rheumatoid Arthritis
7.5.1 Overview
7.5.2 Rheumatoid Arthritis: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Hematological Disorders
7.6.1 Overview
7.6.2 Hematological Disorders: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Diabetes
7.7.1 Overview
7.7.2 Diabetes: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
7.8 Others
7.8.1 Overview
7.8.2 Others: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8. Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 - by Equipment
8.1 Overview
8.2 Middle East & Africa Bioproduction Market Revenue Share, by Equipment 2022 & 2030 (%)
8.3 Consumables and Accessories
8.3.1 Overview
8.3.2 Consumables and Accessories: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Downstream Equipment
8.4.1 Overview
8.4.2 Downstream Equipment: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Bioreactors
8.5.1 Overview
8.5.2 Bioreactors: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
8.5.2.1 Middle East & Africa: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
8.6 Upstream Equipment
8.6.1 Overview
8.6.2 Upstream Equipment: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
9. Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 - by End User
9.1 Overview
9.2 Middle East & Africa Bioproduction Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Biopharmaceutical Companies
9.3.1 Overview
9.3.2 Biopharmaceutical Companies: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Contract Manufacturing Organizations
9.4.1 Overview
9.4.2 Contract Manufacturing Organizations: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10. Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 - Country Analysis
10.1 Middle East & Africa Bioproduction Market
10.1.1.1 Saudi Arabia: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.1 Saudi Arabia: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.2 Saudi Arabia: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.1.3 Saudi Arabia: Bioproduction Market, by Application, 2020-2030 (US$ Million)
10.1.1.1.4 Saudi Arabia: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
10.1.1.1.4.1 Saudi Arabia: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.1.5 Saudi Arabia: Bioproduction Market, by End User, 2020-2030 (US$ Million)
10.1.1.2 South Africa: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 South Africa: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.3 South Africa: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.2.4 South Africa: Bioproduction Market, by Application, 2020-2030 (US$ Million)
10.1.1.2.5 South Africa: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
10.1.1.2.5.1 South Africa: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.2.6 South Africa: Bioproduction Market, by End User, 2020-2030 (US$ Million)
10.1.1.3 UAE: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 UAE: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.3 UAE: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.3.4 UAE: Bioproduction Market, by Application, 2020-2030 (US$ Million)
10.1.1.3.5 UAE: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
10.1.1.3.5.1 UAE: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.3.6 UAE: Bioproduction Market, by End User, 2020-2030 (US$ Million)
10.1.1.4 Rest of Middle East & Africa: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.1 Overview
10.1.1.4.2 Rest of Middle East & Africa: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.3 Rest of Middle East & Africa: Bioproduction Market, by Product, 2020-2030 (US$ Million)
10.1.1.4.4 Rest of Middle East & Africa: Bioproduction Market, by Application, 2020-2030 (US$ Million)
10.1.1.4.5 Rest of Middle East & Africa: Bioproduction Market, by Equipment, 2020-2030 (US$ Million)
10.1.1.4.5.1 Rest of Middle East & Africa: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)
10.1.1.4.6 Rest of Middle East & Africa: Bioproduction Market, by End User, 2020-2030 (US$ Million)
11. Bioproduction Market-Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Bioproduction Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1. Lonza Group AG
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Danaher Corp
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Sartorius AG
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Thermo Fisher Scientific Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Merck KGaA
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 F. Hoffmann-La Roche Ltd
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Bio-Rad Laboratories Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms
?
List of Tables
Table 1. Middle East & Africa Bioproduction Market Segmentation
Table 2. Middle East & Africa Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 3. Saudi Arabia Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 4. Saudi Arabia Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 5. Saudi Arabia Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 6. Saudi Arabia Bioproduction Market, For Bioreactors by Equipment by Application - Revenue and Forecast to 2030 (US$ Million)
Table 7. Saudi Arabia Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 8. South Africa Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 9. South Africa Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 10. South Africa Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 11. South Africa Bioproduction Market, For Bioreactors by Equipment- Revenue and Forecast to 2030 (US$ Million)
Table 12. South Africa Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 13. UAE Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 14. UAE Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 15. UAE Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 16. UAE Bioproduction Market, For Bioreactors by Equipment- Revenue and Forecast to 2030 (US$ Million)
Table 17. UAE Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 18. Rest of Middle East & Africa Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 19. Rest of Middle East & Africa Bioproduction Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 20. Rest of Middle East & Africa Bioproduction Market, by Equipment - Revenue and Forecast to 2030 (US$ Million)
Table 21. Rest of Middle East & Africa Bioproduction Market, For Bioreactors by Equipment- Revenue and Forecast to 2030 (US$ Million)
Table 22. Rest of Middle East & Africa Bioproduction Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 23. Recent Inorganic Growth Strategies in the Bioproduction Market
Table 24. Recent Organic Growth Strategies in the Bioproduction Market
Table 25. Glossary of Terms, Bioproduction Market
?
List of Figures
Figure 1. Middle East & Africa Bioproduction Market Segmentation, By Country
Figure 2. Middle East & Africa Bioproduction Market: Key Industry Dynamics
Figure 3. Middle East & Africa Bioproduction Market: Impact Analysis of Drivers and Restraints
Figure 4. Middle East & Africa Bioproduction Market Revenue (US$ Mn), 2020 - 2030
Figure 5. Middle East & Africa Bioproduction Market Revenue Share, by Product 2022 & 2030 (%)
Figure 6. Biologics and Biosimilars: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Vaccines: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Cell and Gene Therapies: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Nucleic Acid Therapeutics: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Others: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Middle East & Africa Bioproduction Market Revenue Share, by Application 2022 & 2030 (%)
Figure 12. Cancer: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Cardiovascular Diseases: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Rheumatoid Arthritis: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Hematological Disorders: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Diabetes: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Others: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Middle East & Africa Bioproduction Market Revenue Share, by Equipment 2022 & 2030 (%)
Figure 19. Consumables and Accessories: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Downstream Equipment: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Bioreactors: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Upstream Equipment: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Middle East & Africa Bioproduction Market Revenue Share, by End User 2022 & 2030 (%)
Figure 24. Biopharmaceutical Companies: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Contract Manufacturing Organizations: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Others: Middle East & Africa Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Middle East & Africa: Bioproduction Market, by Key Country - Revenue (2022) (US$ Million)
Figure 28. Middle East & Africa: Bioproduction Market, by Country, 2022 & 2030 (%)
Figure 29. Saudi Arabia: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 30. South Africa: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 31. UAE: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 32. Rest of Middle East & Africa: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)
Figure 33. Growth Strategies in the Bioproduction Market
1. Lonza Group AG
2. Danaher Corp
3. Sartorius AG
4. Thermo Fisher Scientific Inc
5. Merck KGaA
6. F. Hoffmann-La Roche Ltd
7. Bio-Rad Laboratories Inc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa bioproduction market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa bioproduction market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the Middle East & Africa bioproduction market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.